Last Updated on June 19, 2021 by The Health Master
BHUBANESWAR: The State Drugs Control Administration issued a show-cause notice to Cuttack-based pharmaceutical wholesaler Medilloyd Medicament Pvt Ltd in connection with the seizure of spurious C-19 drugs.
Deputy Drug Controller-cum-Licensing Authority Mamina Patnaik has asked the pharmaceutical wholesaler to reply within three days, failing which action as per the provisions of the Drugs and Cosmetics Act and Rules will be initiated.
The wholesaler has been issued show cause notice on three clauses as purchase record of drugs intended for resale / wholesale was not maintained and he failed to provide documents during the inspection. Besides, he had purchased drugs from a fictitious manufacturer, which is violation of section 18 (a)(i) of the Act.
The wholesaler had allegedly purchased 58,000 spurious anti-viral drug Favipiravir (Favimax 400) tablets from one Max Relief Health Care, Uttar Pradesh, out of which he had supplied 40,600 tablets to Mahadev Medicals and Surgicals, Gwalior.
Schedules: All types of Clinical Trials
Schedules: All types of Cosmetics
Schedules: All types of Medical Devices
Govt to amend Schedule K to exempt Antiseptics from sale license
India should immediately start Drug Brand Name Registry: Experts
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
